UMN Pharma Inc (4585):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】UMN Pharma Inc (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7628)・商品コード:DATA904C7628
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:24
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
UMN Pharma Inc (UMN Pharma) is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s products include UMN-0501, UMN-0502, UMN-2003, UMN-0901 and UMN-2002, among others. Its UMN-0502 is a seasonal influenza vaccine. UMN Pharma’s UMN-0501 and UMN-0901 are used as pandemic influenza vaccines and others. The company also provides UMN-2003 product, a norovirus VLP – rotavirus VP6 non-live injectable trivalent vaccine for preventing two major causative agents of acute gastroenteritis in one injection. It also partners with universities and pharmaceutical companies for biosimilars business and biopharmaceuticals manufacturing, among others. UMN Pharma is headquartered in Yokohama, Japan.

UMN Pharma Inc (4585) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UMN Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Shionogi and UMN Pharma Enter into Agreement 10
Daiichi Sankyo and UMN Pharma Enter into Research Agreement for Norovirus Vaccine 11
Catalent Pharma Solutions Enters Into Agreement With UMN Pharma For Biosimilar Development 12
Licensing Agreements 13
UMN Pharma Enters Into Licensing Agreement With University of Tampere Vaccine Research Center 13
Equity Offering 14
UMN Pharma Completes Private Placement Of Shares For US$10 Million 14
UMN Pharma Inc – Key Competitors 15
UMN Pharma Inc – Key Employees 16
UMN Pharma Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Jul 31, 2018: UMN Pharma: Non-consolidated financial results for the first six months of fiscal year ending Dec. 31, 2017 18
Oct 31, 2017: UMN Pharma: Non-consolidated Financial Results for the First Nine Months of Fiscal Year Ending Dec. 31, 2017 21
Apr 28, 2017: UMN Pharma: Non-consolidated Financial Results for the First Three Months of Fiscal Year Ending Dec. 31, 2017 22
Feb 20, 2017: UNM Pharma: Revision of Consolidated Financial Results For the Fiscal Year Ending December 31, 2016 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
UMN Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UMN Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UMN Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shionogi and UMN Pharma Enter into Agreement 10
Daiichi Sankyo and UMN Pharma Enter into Research Agreement for Norovirus Vaccine 11
Catalent Pharma Solutions Enters Into Agreement With UMN Pharma For Biosimilar Development 12
UMN Pharma Enters Into Licensing Agreement With University of Tampere Vaccine Research Center 13
UMN Pharma Completes Private Placement Of Shares For US$10 Million 14
UMN Pharma Inc, Key Competitors 15
UMN Pharma Inc, Key Employees 16
UMN Pharma Inc, Other Locations 17
UMN Pharma Inc, Subsidiaries 17

List of Figures
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UMN Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★調査レポート[UMN Pharma Inc (4585):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C7628)販売に関する免責事項を必ずご確認ください。
★調査レポート[UMN Pharma Inc (4585):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆